Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Environmental Monitoring in the Manufacturing Area

Posted on By

SOP for Environmental Monitoring in the Manufacturing Area

Standard Operating Procedure for Environmental Monitoring in the Manufacturing Area

1) Purpose

The purpose of this SOP is to establish procedures for monitoring and controlling the environmental conditions within the pharmaceutical manufacturing area to ensure compliance with regulatory requirements and maintain product quality.

2) Scope

This SOP applies to all environmental monitoring activities conducted in the pharmaceutical manufacturing facility.

3) Responsibilities

3.1 Environmental Monitoring Team

  • Perform routine monitoring of critical parameters such as air quality and surface cleanliness.
  • Record and report monitoring results promptly to relevant personnel.
See also  SOP for In-process Monitoring and Control during FFS Operations

3.2 Quality Assurance (QA) Personnel

  • Review environmental monitoring data for trends and deviations.
  • Initiate corrective and preventive actions (CAPA) in response to environmental excursions.

4) Procedure

4.1 Monitoring Parameters

  1. Monitor airborne particulates, microbial levels, and temperature/humidity conditions.
  2. Conduct surface sampling for microbial contamination on critical surfaces.

4.2 Sampling Locations

  1. Select sampling locations based on risk assessment and regulatory requirements.
  2. Ensure representative sampling across different areas of the manufacturing facility.

4.3 Sampling Methods

  1. Use validated methods and equipment for air and surface sampling.
  2. Follow aseptic techniques during sample collection to prevent contamination.

4.4 Data Analysis and Reporting

  1. Analyze monitoring data for trends and deviations from established limits.
  2. Document findings in environmental monitoring records and notify relevant stakeholders.
See also  SOP for Sampling Procedures for Raw Materials and Finished Products

5) Abbreviations, if any

QA: Quality Assurance
CAPA: Corrective and Preventive Actions

6) Documents, if any

  • Environmental Monitoring
Plan
  • Sampling and Testing Protocols
  • Environmental Monitoring Reports
  • 7) Reference, if any

    EU GMP Annex 1: Manufacture of Sterile Medicinal Products
    ISO 14644: Cleanrooms and associated controlled environments

    8) SOP Version

    Version 1.0

    Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

    Post navigation

    Previous Post: SOP for Particle Size Distribution in Gels
    Next Post: SOP for Reference Standard Management

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version